PTPRC and neoplasm: Immunohistochemical CD45 stainings corroborated the immunophenotyping by identifying an increased number of immune cells over time in the tumor stroma, but also immune cells infiltrating into the tumor tissue at 3 and 6 w p.i. (Figure 6), when tumor cells became invasive.